Skip to main content

Leukemic Infiltration of the Optic Nerve

  • Chapter
  • First Online:
Controversies in Neuro-Ophthalmic Management

Abstract

Leukemic infiltration of the optic nerve is an uncommon condition, although its incidence has increased as more effective oncologic and supportive therapy has improved survival among patients with leukemia. Since both the central nervous system and the eye are immunoprivileged sites, they may not be reached by systemic chemotherapy. Therefore, leukemic cells can be harbored in these spaces, even when treatment has eliminated the leukemia elsewhere in the body. Furthermore, when leukemic cells infiltrate the ocular structures, including the intraocular portion of the optic nerve, even intrathecal chemotherapy may not be adequate to eliminate them. Due to the rarity of leukemic infiltration of the optic nerve, there are no randomized controlled trials or other prospective studies evaluating its management. However, treatment with whole brain and directed optic nerve radiation, along with intrathecal chemotherapy and steroids, may be successful for preserving vision or preventing further vision loss, while also treating the underlying disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schachat AP, Markowitz JA, Guyer DR, Burke PJ, Karp JE, Graham ML. Ophthalmic manifestations of leukemia. Arch Ophthalmol. 1989;107(5):697–700.

    Article  CAS  Google Scholar 

  2. Rosenthal AR. Ocular manifestations of leukemia. Ophthalmology. 1983;90(8):899–905. https://doi.org/10.1016/s0161-6420(83)80013-x.

    Article  CAS  PubMed  Google Scholar 

  3. Murray KH, Paolino F, Goldman JM, Galton DA, Grindle CF. Ocular involvement in leukaemia. Report of three cases. Lancet. 1977;16(1):829–31.

    Article  Google Scholar 

  4. Ohkoshi K, Tsiaras WG. Prognostic importance of ophthalmic manifestations in childhood leukaemia. Br J Ophthalmol. 1992;76(11):651–5.

    Article  CAS  Google Scholar 

  5. Reddy SC, Jackson N, Menon BS. Ocular involvement in leukemia–a study of 288 cases. Ophthalmologica. 2003;217(6):441–5. https://doi.org/10.1159/000073077.

    Article  CAS  PubMed  Google Scholar 

  6. Karesh JW, Goldman EJ, Reck K, Kelman SE, Lee EJ, Schiffer CA. A prospective ophthalmic evaluation of patients with acute myeloid leukemia: correlation of ocular and hematologic findings. Clin J Oncol. 1989;7(10):1528–32.

    Article  CAS  Google Scholar 

  7. Russo V, Scott IU, Querques G, Stella A, Barone A, Delle Noci N. Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol. 2008;18(4):619–23.

    Article  CAS  Google Scholar 

  8. Kincaid MC, Green WR. Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983;27(4):211–32.

    Article  CAS  Google Scholar 

  9. Dua T, Chandra J, Arora M, Saxena YK, Jain R, Narayan S. Isolated ocular relapse in acute lymphoblastic leukemia. Indian J Pediatr. 1999;66(3):470–2.

    Article  CAS  Google Scholar 

  10. Schwartz CL, Miller NR, Wharam MD, Leventhal BG. The optic nerve as the site of initial relapse in childhood acute lymphoblastic leukemia. Cancer. 1989;63(8):1616–20.

    Article  CAS  Google Scholar 

  11. Mayo GL, Carter JE, McKinnon SJ. Bilateral optic disk edema and blindness as initial presentation of acute lymphocytic leukemia. Am J Ophthalmol. 2002;134(1):141–2.

    Article  Google Scholar 

  12. Randhawa S, Ruben J. Leukemic optic nerve infiltration. Ophthalmology. 2017;124(3):277. https://doi.org/10.1016/j.ophtha.2016.08.002.

    Article  PubMed  Google Scholar 

  13. Brown GC, Shields JA, Augsburger JJ, Serota FT, Koch P. Leukemic optic neuropathy. Int Ophthalmol. 1981;3(2):111–6.

    Article  CAS  Google Scholar 

  14. Coombs CC, DeAngelis LM, Feusner JH, Rowe JM, Tallman MS. Pseudotumor cerebri in acute promyelocytic leukemia patients on intergroup protocol 0129: clinical description and recommendations for new diagnostic criteria. Clin Lymphoma Myeloma Leuk. 2016;16(3):146–51. https://doi.org/10.1016/j.clml.2015.11.018.

    Article  PubMed  Google Scholar 

  15. Culler AM. Fundus changes in leukemia. Trans Am Ophthalmol Soc. 1951;49:445–73.

    PubMed  PubMed Central  Google Scholar 

  16. Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci. 1998;39(1):134–42.

    CAS  PubMed  Google Scholar 

  17. Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP, Group NIIHS. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 2015;85(9):799–805.

    Article  CAS  Google Scholar 

  18. Ellis W, Little HL. Leukemic infiltration of the optic nerve head. Am J Ophthalmol. 1973;75(5):867–71. https://doi.org/10.1016/0002-9394(73)90893-3.

    Article  CAS  PubMed  Google Scholar 

  19. LaRiviere MJ, Avery RA, Dolan JG, Adamson PC, Zarnow DM, Xie Y, Avery SM, Kurtz GA, Hill-Kayser CE, Lustig RA, Lukens JN. Emergent radiation for leukemic optic nerve infiltration in a child receiving intrathecal methotrexate. Pract Radiat Oncol. 2019;9(4):226–30. https://doi.org/10.1016/j.prro.2019.04.004.

    Article  PubMed  Google Scholar 

  20. Wang A-G. Leukemic infiltrative optic neuropathy. In: Emergency Neuro-ophthalmology; 2018;17–22. https://doi.org/10.1007/978-981-10-7668-8_3.

  21. Ninane J, Taylor D, Day S. The eye as a sanctuary in acute lymphoblastic leukemia. Lancet. 1980;1:452–3.

    Article  CAS  Google Scholar 

  22. Pinnix CC, Yahalom J, Specht L, Dabaja BS. Radiation in central nervous system leukemia: guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2018;102(1):53–8. https://doi.org/10.1016/j.ijrobp.2018.05.067.

    Article  PubMed  Google Scholar 

  23. Rozovski U, Ohanian M, Ravandi F, Garcia-Manero G, Faderl S, Pierce S, Cortes J, Estrov Z. Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia. Leuk Lymphoma. 2015;56(5):1392–7. https://doi.org/10.3109/10428194.2014.953148.

    Article  CAS  PubMed  Google Scholar 

  24. Slevin ML, Piall EM, Aherne GW, Harvey VJ, Johnston A, Lister TA. Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. J Clin Oncol. 1983;1(9):546–51.

    Article  CAS  Google Scholar 

  25. Killer HE, Laeng HR, Flammer J, Groscurth P. Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations. Br J Ophthalmol. 2003;87:777–81.

    Article  CAS  Google Scholar 

  26. Ridgway EW, Jaffe N, Walton DS. Leukemic ophthalmopathy in children. Cancer. 1976;38(4):1744–9.

    Article  CAS  Google Scholar 

  27. Reinstein LE. The effect of patient position on radiotherapy protocol deviations in the treatment of acute lymphocytic leukemia. Am J Clin Oncol. 1982;5(3):303–6.

    Article  CAS  Google Scholar 

  28. Kaikov Y. Optic nerve head infiltration in acute leukemia in children: an indication for emergency optic nerve radiation therapy. Med Pediatr Oncol. 1996;26(2):101–4.

    Article  CAS  Google Scholar 

  29. Puvanachandra N, Goddard K, Lyons CJ. Dramatic visual recovery after prompt radiotherapy and chemotherapy for leukaemic infiltration of the optic nerve in a child. Eye (Lond). 2010;24(5):927–8. https://doi.org/10.1038/eye.2009.204.

    Article  CAS  Google Scholar 

  30. Shibasaki H, Hayasaka S, Noda S, Masaki Y, Yamamoto D. Radiotherapy resolves leukemic involvement of the optic nerves. Ann Ophthalmol. 1992;24(10):395–7.

    CAS  PubMed  Google Scholar 

  31. Verter E, Yang A, Lim RP. Leukemic optic nerve infiltration responds to radiation and blinatumomab. Ophthalmology. 2018;125(5):746. https://doi.org/10.1016/j.ophtha.2018.01.024.

    Article  PubMed  Google Scholar 

  32. Evans ML, Graham MM, Mahler PA, Rasey JS. Use of steroids to suppress vascular response to radiation. Int J Radiat Oncol Biol Phys. 1987;13(4):563–7.

    Article  CAS  Google Scholar 

  33. Bandyopadhyay S, Das D, Das G, Gayen S. Unilateral optic nerve infiltration as an initial site of relapse of acute lymphoblastic leukemia in remission. Oman J Ophthalmol. 2010;3(3):153–4. https://doi.org/10.4103/0974-620X.71902.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lin YC, Wang AG, Yen MY, Hsu WM. Leukaemic infiltration of the optic nerve as the initial manifestation of leukaemic relapse. Eye (Lond). 2004;18(5):546–50. https://doi.org/10.1038/sj.eye.6700701.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emma C. McDonnell .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McDonnell, E.C., Henderson, A.D. (2021). Leukemic Infiltration of the Optic Nerve. In: Henderson, A.D., Carey, A.R. (eds) Controversies in Neuro-Ophthalmic Management. Springer, Cham. https://doi.org/10.1007/978-3-030-74103-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-74103-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-74102-0

  • Online ISBN: 978-3-030-74103-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics